Skip to main content

Table 1 (abstract P34). Treatment modalities and outcomes in patient with DADA2

From: Abstracts from the ISSAID 2021 Periodic Congress

Treatment Clinical symptoms Laboratory tests
Vasculitis Hepato-splenomegaly Fever Hb,
g/l
PLT,
109/l
WBC,
cells/μl
NEU,
cells/μl
LYM,
cells/μl
CRP,
mg/l
Before treatment +++ +++ +++ 59 n/a n/a n/a n/a n/a
Steroids,
0,1-30 mg/kg
+ - +/- 133 109 3740 2403 760 16,4
Etanercept,
0,8 mg/kg
- - - 52 49 610 200 270 4,62
Etanercept 0,8 mg/kg + steroids 1 mg/kg - - - 144 62 3898 2447 535 1,6
Ruxolitinib,
10 mg/m2
- - - 154 91 5890 4317 967 1,4
  1. Hb – hemoglobin, PLT – platelet count, WBC – white blood cell count, NEU – neutrophil count, LYM – lymphocyte count, CRP – C-reactive protein. Laboratory test results show median values for the observation time